Viking Global joins Orbimed investing in new IPO Sionna Therapeutics; New 6.7% stake $SION

Another top tier firm is investing in new IPO Sionna Therapeutics $SION (market cap: $851m). Yesterday, we saw Orbimed taking an 8.4% stake (Link). Now it's Viking Global with a 6.7% initial stake (SEC filing). Here's more on $SION:

• Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments

https://seekingalpha.com/article/4751851-sionna-therapeutics-seeks-100-million-ipo-for-cystic-fibrosis-treatments